Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H4 | Q96RI1 | 15/20 | 0.49 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29881726 | 1.00 | NR1H4 (0.49) | NR1H4MAPTCYP3A4CYP2D6CYP2C9 | |
| SCHEMBL3560237 | 1.00 | NR1H4 (0.49) | NR1H4MAPTCYP3A4CYP2D6CYP2C9 | |
| SCHEMBL3566070 | 0.93 | NR1H4 (0.50) | NR1H4CYP3A4CYP2D6CYP2C9POLB | |
| Hydrochloric Acid SCHEMBL3575969 | 0.92 | NR1H4 (0.52) | NR1H4CYP3A4CYP2D6CYP2C9POLB | |
| Hydrochloric Acid SCHEMBL3575967 | 0.91 | NR1H4 (0.51) | NR1H4CYP3A4CYP2D6CYP2C9POLB | |
| SCHEMBL29880834 | 0.88 | NR1H4 (0.64) | NR1H4CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL3576255 | 0.88 | NR1H4 (0.64) | NR1H4CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL29880550 | 0.88 | NR1H4 (0.64) | NR1H4CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL3558528 | 0.88 | NR1H4 (0.64) | NR1H4CYP3A4CYP2D6CYP2C9 | |
| SCHEMBL198965 | 0.88 | NR1H4 (0.64) | NR1H4CYP3A4CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110404073-B | Methods and pharmaceutical compositions for treating hepatitis B virus infection | 国家医疗保健研究所 | 2022-08-16 | — | — | CN | disclosed |
| EP-3043865-B1 | METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION | INST NAT SANTE RECH MED (FR) | 2020-11-04 | — | — | EP | disclosed |